This paper is in the following e-collection/theme issue:

Pharmacovigilance (134) mHealth for Wellness, Behavior Change and Prevention (2871) Mobile Health (mhealth) (2939) Influenza and Influenza-Like-Illness (ILI) Surveillance (217) Infectious Diseases (non-STD/STI) (1575) Vaccination and Immunization in the Digital Age (374) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Surveillance Systems (462) Public (e)Health, Digital Epidemiology and Public Health Informatics (725)

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/39700, first published .
Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Comparing the Use of a Mobile App and a Web-Based Notification Platform for Surveillance of Adverse Events Following Influenza Immunization: Randomized Controlled Trial

Authors of this article:

A Brianne Bota1 Author Orcid Image ;   Julie A Bettinger2 Author Orcid Image ;   Shirley Sarfo-Mensah1 Author Orcid Image ;   Jimmy Lopez2 Author Orcid Image ;   David P Smith1 Author Orcid Image ;   Katherine M Atkinson3 Author Orcid Image ;   Cameron Bell4 Author Orcid Image ;   Kim Marty2 Author Orcid Image ;   Mohamed Serhan1 Author Orcid Image ;   David T Zhu1, 5 Author Orcid Image ;   Anne E McCarthy6 Author Orcid Image ;   Kumanan Wilson1, 4, 6, 7 Author Orcid Image
Article Authors Cited by (2) Tweetations (3) Metrics

A Brianne Bota   1 , PhD ;   Julie A Bettinger   2 , MPH, PhD ;   Shirley Sarfo-Mensah   1 , MPH ;   Jimmy Lopez   2 , BSc ;   David P Smith   1 , MCogSc ;   Katherine M Atkinson   3 , BSc ;   Cameron Bell   4 , BEng ;   Kim Marty   2 , BSc ;   Mohamed Serhan   1 , BSc, HBsc ;   David T Zhu   1, 5 , BSc ;   Anne E McCarthy   6 , MD, MSc, DTM&H ;   Kumanan Wilson   1, 4, 6, 7 , MD, MSc

1 Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada

2 Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, BC, Canada

3 Karolinska Institutet, Solna, Sweden

4 CanImmunize Inc, Ottawa, ON, Canada

5 Department of Social and Behavioral Sciences, Yale School of Public Health, New Haven, CT, United States

6 Department of Medicine, University of Ottawa, Ottawa, ON, Canada

7 Bruyère Research Institute, Ottawa, ON, Canada

Corresponding Author:

  • Kumanan Wilson, MD, MSc
  • Clinical Epidemiology Program
  • Ottawa Hospital Research Institute
  • 1053 Carling Avenue
  • Administrative Service Building, Box 684
  • Ottawa, ON, K1Y 4E9
  • Canada
  • Phone: 1 6137985555 ext 17921
  • Email: kwilson@toh.ca